Johannes Sebastian Mutzenbach

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

Milan R. Voško, Christof Bocksrucker, Rafał Drwiła et al. · Journal of Thrombosis and Thrombolysis · 2017 · 56 citations · Full text

Patient Safety, Emergency Situations, Real-life Experience +4

Ignoring floor and ceiling effects may underestimate the effect of carotid artery stenting on cognitive performance

Martin Scherr, Alexander Kunz, Anselm Doll et al. · Journal of NeuroInterventional Surgery · 2015 · 33 citations

Fibrinogen consumption is related to intracranial clot burden in acute ischemic stroke: a retrospective hyperdense artery study

Slaven Pikija, Vladimir Trkulja, Johannes Sebastian Mutzenbach et al. · Journal of Translational Medicine · 2016 · 33 citations · Full text

Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab – a case report

Johannes Sebastian Mutzenbach, Slaven Pikija, Ferdinand Otto et al. · Annals of Clinical and Translational Neurology · 2016 · 32 citations · Full text